|
|||||
|
|
Effective CMV prophylaxis with high-dose valaciclovir in allogeneic hematopoietic stem-cell recipients at a high risk of CMV infection |
|
| Authors: | Genevieve Douglas Michelle K. Yong Shio Yen Tio Maggie Chau Ashvind Prabahran Joe Sasadeusz Monica Slavin David Ritchie Lynette Chee |
| Affiliation: | 1. Department of Clinical Haematology and Bone Marrow Transplantation, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, Australia;2. Department of Infectious Diseases, Royal Melbourne Hospital, Parkville, Australia National Centre for Infections in Cancer, Parkville, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia;3. Department of Clinical Haematology and Bone Marrow Transplantation, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, Australia Pharmacy Department, Royal Melbourne Hospital, Parkville, Victoria, Australia;4. Department of Infectious Diseases, Royal Melbourne Hospital, Parkville, Australia;5. Department of Clinical Haematology and Bone Marrow Transplantation, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, Australia Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia;6. Department of Clinical Haematology and Bone Marrow Transplantation, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Parkville, Australia Department of Medicine, University of Melbourne, Melbourne, Australia |
| Abstract: | |
| Keywords: | bone marrow transplant CMV prophylaxis valaciclovir |